Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Eur J Surg Oncol. 2021 Apr 17;47(10):2667–2674. doi: 10.1016/j.ejso.2021.04.013

Table 5.

Univariable and Multivariable Cox models for recurrence-free survival.

Univariable Multivariable

variable Hazard Ratio [95% CI] p-value Hazard Ratio [95% CI] p-value
Age ≥ 70 years (ref. <70) 0.832 [0.496, 1.396] 0.4869 1.594 [0.812, 3.130] 0.163
Neoadjuvant, completion Reference Reference
Neoadjuvant, dose reduced 0.811 [0.325, 2.020] 0.6525 0.697 [0.204, 2.379] 0.5646
Neoadjuvant, discontinued 1.196 [0.546, 2.621] 0.6542 2.784 [0.939, 8.258] 0.0649
Radiation dose, less than or equal 4500 g y Reference Reference
Radiation dose >4500–5000 g y 1.781 [0.378, 8.393] 0.4653 0.895 [0.163, 4.918] 0.8983
Radiation dose >5000 g y 1.296 [0.603, 2.783] 0.5066 0.992 [0.436, 2.258] 0.9843
Surgery within 8 weeks of neoadjuvant (ref >8 weeks) 0.753 [0.466, 1.218] 0.2479 0.443 [0.230, 0.854] 0.015
Squamous cell Carcinoma (ref. Adenocarcinoma) 0.534 [0.231, 1.235] 0.1427 1.129 [0.382, 3.332] 0.8263
Pathological Stage T1/T2 (ref. pT0) 2.649 [1.241, 5.658] 0.0118 2.485 [0.772, 8.000] 0.1269
Pathological stage T3/T4 (ref. pT0) 5.180 [2.486, 10.796] <0.0001 4.947 [1.481, 16.531] 0.0094
Pathologic nodal disease N1–N3 (ref. pN0) 3.075 [1.924, 4.915] <0.0001 2.308 [1.130, 4.716] 0.0217
Lymphovascular invasion (ref. no) 2.673 [1.574, 4.539] 0.0003 2.229 [1.057, 4.699] 0.0352

CI = confidence interval; Gy = Grey; N=Node descriptor; P = pathologic; T = tumor descriptor.